751 related articles for article (PubMed ID: 25894563)
1. A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K727, K733) with the oxime HI-6 and obidoxime in sarin-poisoned rats and mice.
Kassa J; Sepsova V; Matouskova L; Horova A; Musilek K
Toxicol Mech Methods; 2015 Mar; 25(3):229-33. PubMed ID: 25894563
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the potency of a novel bispyridinium oxime K203 and currently available oximes (obidoxime, HI-6) to counteract the acute neurotoxicity of sarin in rats.
Kassa J; Misik J; Karasova JZ
Basic Clin Pharmacol Toxicol; 2012 Nov; 111(5):333-8. PubMed ID: 22536919
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the reactivating and therapeutic efficacy of two newly developed oximes (k727 and k733) with oxime k203 and trimedoxime in tabun-poisoned rats and mice.
Kassa J; Sepsova V; Tumova M; Horova A; Musilek K
Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):367-71. PubMed ID: 25225130
[TBL] [Abstract][Full Text] [Related]
5. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with presently used oximes and H oximes against sarin by in vitro and in vivo methods.
Kassa J; Cabal J
Hum Exp Toxicol; 1999 Sep; 18(9):560-5. PubMed ID: 10523870
[TBL] [Abstract][Full Text] [Related]
7. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
Kassa J; Karasova JZ; Pavlikova R; Misik J; Caisberger F; Bajgar J
J Appl Toxicol; 2010 Mar; 30(2):120-4. PubMed ID: 19746406
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of reactivating and therapeutic efficacy of newly developed oximes (K206, K269) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Bajgar J
Clin Toxicol (Phila); 2009 Jan; 47(1):72-6. PubMed ID: 18686075
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the efficacy of new asymmetric bispyridinium oxime BI-6 with other oximes (obidoxime, HI-6) against soman in rats.
Kassa J
Hum Exp Toxicol; 1998 Jun; 17(6):331-5. PubMed ID: 9688357
[TBL] [Abstract][Full Text] [Related]
10. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
[TBL] [Abstract][Full Text] [Related]
11. The benefit of combinations of oximes for the reactivating and therapeutic efficacy of antidotal treatment of sarin poisoning in rats and mice.
Kassa J; Karasova JZ; Sepsova V; Caisberger F
Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):30-4. PubMed ID: 21235715
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K; Jung YS
Drug Chem Toxicol; 2008; 31(3):371-81. PubMed ID: 18622871
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
[TBL] [Abstract][Full Text] [Related]
14. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of soman poisoning in rats and mice.
Kassa J; Karasova JZ; Caisberger F; Bajgar J
Toxicol Mech Methods; 2009 Nov; 19(9):547-51. PubMed ID: 19839724
[TBL] [Abstract][Full Text] [Related]
15. Bispyridinium oximes as antidotal treatment of cyclosarin poisoning-in vitro and in vivo testing.
Bartosova L; Kuca K; Jun D; Kunesova G
Int J Toxicol; 2005; 24(6):399-402. PubMed ID: 16393932
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
[TBL] [Abstract][Full Text] [Related]
17. The benefit of combination of oximes for the neuroprotective efficacy of antidotal treatment of sarin-poisoned rats.
Kassa J; Kunesova G
Toxicol Mech Methods; 2012 May; 22(4):260-7. PubMed ID: 22149934
[TBL] [Abstract][Full Text] [Related]
18. A comparison of reactivating and therapeutic efficacy of newly-developed oximes (K156, K203) and commonly used oximes (obidoxime, HI-6) in cyclosarin-poisoned rats and mice.
Kassa J; Karasova JZ; Musilek K; Kuca K
Toxicol Mech Methods; 2009 Jun; 19(5):346-50. PubMed ID: 19778210
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods.
Kuca K; Cabal J; Kassa J
J Toxicol Environ Health A; 2005 Apr; 68(8):677-86. PubMed ID: 15901095
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
Kassa J; Bajgar J
Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]